Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Resch

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer, , , et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgeryVratislav Strnad, Guido Hildebrandt, Richard Pötter, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrenceOliver J Ott, Guido Hildebrandt, Richard Pötter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2002
Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancerAlexandra Resch, Richard Pötter, Erik Van Limbergen, et al.
The Lancet. Oncology|February 4, 2023
Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trialVratislav Strnad, Csaba Polgár, Oliver J Ott, et al.
The Lancet. Oncology|January 18, 2017
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trialCsaba Polgár, Oliver J Ott, Guido Hildebrandt, et al.
The Lancet. Oncology|April 27, 2018
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trialRebekka Schäfer, Vratislav Strnad, Csaba Polgár, et al.
Lancet (London, England)|October 24, 2015
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trialVratislav Strnad, Oliver J Ott, Guido Hildebrandt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 17, 2016
GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient complianceOliver J Ott, Vratislav Strnad, Guido Hildebrandt, et al.
Scientific Reports|August 27, 2022
Current trends and outcomes of non-elective neurosurgical care in Central Europe during the second year of the COVID-19 pandemicOndra Petr, Lukas Grassner, Freda M Warner, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer, , , et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgeryVratislav Strnad, Guido Hildebrandt, Richard Pötter, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrenceOliver J Ott, Guido Hildebrandt, Richard Pötter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2002
Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancerAlexandra Resch, Richard Pötter, Erik Van Limbergen, et al.
The Lancet. Oncology|February 4, 2023
Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trialVratislav Strnad, Csaba Polgár, Oliver J Ott, et al.
The Lancet. Oncology|January 18, 2017
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trialCsaba Polgár, Oliver J Ott, Guido Hildebrandt, et al.
The Lancet. Oncology|April 27, 2018
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trialRebekka Schäfer, Vratislav Strnad, Csaba Polgár, et al.
Lancet (London, England)|October 24, 2015
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trialVratislav Strnad, Oliver J Ott, Guido Hildebrandt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 17, 2016
GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient complianceOliver J Ott, Vratislav Strnad, Guido Hildebrandt, et al.
Scientific Reports|August 27, 2022
Current trends and outcomes of non-elective neurosurgical care in Central Europe during the second year of the COVID-19 pandemicOndra Petr, Lukas Grassner, Freda M Warner, et al.
Pageof 4